Seres Therapeutics, Inc. (MCRB)

CIK 1609809 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Seres Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 2026EFFECT9999999995-26-002733
Aug 18, 202640001193125-26-355722
Aug 18, 202640001193125-26-355734
Aug 18, 202640001193125-26-355718
Aug 18, 202640001193125-26-355712
Aug 13, 2026S-30001193125-26-349330
Aug 5, 202610-Q0001193125-26-334174
Aug 5, 20268-K0001193125-26-333820
Aug 4, 2026424B50001193125-26-332730
Aug 4, 20268-K0001193125-26-332742
Jul 10, 202640001193125-26-300919
Jul 10, 202640001193125-26-300921
Jul 10, 202640001193125-26-300925
Jul 10, 202640001193125-26-300923
Jul 10, 202640001193125-26-300927
Jul 10, 202640001193125-26-300916
Jul 10, 202640001193125-26-300920
Jul 10, 202640001193125-26-300914
Jul 10, 202640001193125-26-300926
Jul 10, 202640001193125-26-300918
Jul 10, 202640001193125-26-300924
Jul 10, 202640001193125-26-300922
Jul 9, 2026S-80001193125-26-299675
Jul 8, 20268-K0001193125-26-298525
Jul 8, 20268-K0001193125-26-298005